Iterum Therapeutics plc
ITRMF$19M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaDUBLIN 19 employees
Drugs in Pipeline
4
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ITRMF News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Ertapenem
Intra Abdominal Infections
Sulopenem
Complicated Urinary Tract Infections
Sulopenem etzadroxil/probenecid
Urinary Tract Infections
Sulopenem-Etzadroxil/Probenecid
Uncomplicated Urinary Tract Infections
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Ertapenem | Phase 3 | Intra Abdominal Infections | - | - |
Sulopenem | Phase 3 | Complicated Urinary Tract Infections | - | - |
Sulopenem etzadroxil/probenecid | Phase 3 | Urinary Tract Infections | - | - |
Sulopenem-Etzadroxil/Probenecid | Phase 3 | Uncomplicated Urinary Tract Infections | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply